| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |